Smad3 mediates the TGF-?-induced contraction of type I collagen gels by mouse embryo fibroblasts
Xiangde Liu,Fu-Qiang Wen,Tetsu Kobayashi,Shinji Abe,Qiuhong Fang,Ester Piek,Erwin P. Bottinger,Anita B. Roberts,Stephen I. Rennard
DOI: https://doi.org/10.1002/cm.10098
2003-01-01
Cell Motility and the Cytoskeleton
Abstract:TGF-beta signals through TGF-beta receptors and Smad proteins. TGF-beta also augments fibroblast-mediated collagen gel contraction, an in vitro model of connective tissue remodeling. To investigate the importance of Smad2 or Smad3 in this augmentation process, embryo-derived fibroblasts from mice lacking expression of Smad2 or Smat/3 genes were cast into native type I collagen gels. Fibroblast-populated gels were then released into 0.2% FCS-DMEM alone or with recombinant human TGF-beta1, beta2, beta3, or recombinant rat PDGF-BB. Gel contraction was determined using an image analyzer. All three isoforms of TGF-beta significantly augmented contraction of collagen gets mediated by fibroblasts with genotypes of Smad2 knockout (S2KO), Smad2 wildtype (S2WT), and Smad3 wildtype (S3WT), but not Smad3 knockout (S3KO) mice. PDGF-BB augmented collagen gel contraction by all fibroblast types. These results suggest that expression of Smad3 but not Smad2 may be critical in TGF-beta augmentation of fibroblast-mediated collagen gel contraction. Thus, the Smad3 gene could be a target for blocking contraction of fibrotic tissue induced by TGF-beta. Cell Motil. Cytoskeleton 54:248-253, 2003. (C) 2003 Wiley-Liss, Inc.
What problem does this paper attempt to address?